Vicore Pharma: Phase II in SSc Patients on Track

Research Note

2020-08-25

11:43

Redeye gives a brief comment to today’s news that Vicore has resumed recruitment to its Phase II trial with C21 in patients with systemic sclerosis (SSc).

LS

Ludvig Svensson

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.